Síndrome de resistencia a las hormonas tiroideas: reporte de un caso

  • Johnayro Gutiérrez Restrepo Universidad de Antioquia, Hospital Pablo Tobón Uribe
  • Julián Felipe Montoya Escobar Universidad de Antioquia
Palabras clave: hormonas tiroideas, receptores beta de hormona tiroidea, síndrome de resistencia a hormonas tiroideas.

Resumen

El síndrome de resistencia a las hormonas tiroideas es una entidad poco frecuente que se caracteriza por concentraciones elevadas de tiroxina libre y triyodotironina libre, tirotropina normal o ligeramente elevada, en ausencia de cualquier otra enfermedad, medicación o antagonista que causen alteraciones sobre la función tiroidea. Se reporta un caso de una mujer a quien se le realizó diagnóstico de resistencia a las hormonas tiroideas con base en los antecedentes personales, las manifestaciones clínicas y los hallazgos de laboratorio; además, se realiza una revisión de la literatura, con énfasis en el diagnóstico y el tratamiento de la enfermedad.

Descargas

La descarga de datos todavía no está disponible.

Biografía del autor/a

Johnayro Gutiérrez Restrepo, Universidad de Antioquia, Hospital Pablo Tobón Uribe

Médico Internista y Endocrinólogo, Universidad de Antioquia. Docente del Servicio de Endocrinología y Metabolismo, Universidad de Antioquia. Endocrinólogo Hospital Pablo Tobón Uribe, Medellín, Colombia.

Julián Felipe Montoya Escobar, Universidad de Antioquia

Médico Internista, Universidad de Antioquia. Residente de Endocrinología y Metabolismo, Universidad de Antioquia, Medellín, Colombia.

Citas

López JM, Jiménez M, Campino C. Resistencia generalizada a hormonas tiroideas de carácter familiar. Rev Méd Chile 2004; 132: 1096-1099.

https://doi.org/10.4067/S0034-98872004000900011

Olateju TO, Vanderpump MP. Thyroid hormone resistance. Ann Clin Biochem 2006; 43: 431-440.

https://doi.org/10.1258/000456306778904678

Refetoff S, DeWind LT, DeGroot LJ. Familial syndrome combining deaf-mutism, stuppled epiphyses, goiter and abnormally high PBI: possible target organ refractoriness to thyroid hormone. J Clin Endocrinol Metab 1967; 27: 279-294.

https://doi.org/10.1210/jcem-27-2-279

Weiss RE, Refetoff S. Resistance to thyroid hormone. Rev Endocr Metab Disord 2000; 1: 97-108.

https://doi.org/10.1023/A:1010072605757

Beck-Peccoz P, Chatterjee VK. The variable clinical phenotype in thyroid hormone resistance syndrome. Thyroid 1994; 4: 225-232.

https://doi.org/10.1089/thy.1994.4.225

Beck-Peccoz P, Persani L, Calebiro D, Bonomi M, Mannavola D, Campi I. Syndromes of hormone resistance in the hypothalamic-pituitary-thyroid axis. Best Pract Res Clin Endocrinol Metab 2006; 20: 529-546.

https://doi.org/10.1016/j.beem.2006.11.001

Kim TJ, Travers S. Case report: thyroid hormone resistance and its therapeutic challenges. Curr Opin Pediatr 2008; 20: 490-493.

https://doi.org/10.1097/MOP.0b013e328305e428

Parikh S, Ando S, Schneider A, Skarulis MC, Sarlis NJ, Yen PM. Resistance to thyroid hormone in a patient without thyroid hormone receptor mutations. Thyroid 2002; 12: 81-86.

https://doi.org/10.1089/105072502753452011

Refetoff S. The syndrome of resistance to thyroid stimulating hormone. J Chin Med Assoc 2003; 66: 441-452.

Refetoff S, Weiss RE, Usala SJ. The syndromes of resistance to thyroid hormone. Endocr Rev 1993; 14: 348-399.

https://doi.org/10.1210/edrv-14-3-348

Refetoff S. Resistance to thyrotropin. J Endocrinol Invest 2003; 26: 770-779.

https://doi.org/10.1007/BF03347364

Takeda K, Sakurai A, DeGroot LJ, Refetoff S. Recessive inheritance of thyroid hormone resistance caused by complete deletion of the protein-coding region of the thyroid hormone receptor-beta gene. J Clin Endocrinol Metab 1992; 74: 49-55.

https://doi.org/10.1210/jcem.74.1.1727829

Taniyama M, Ishikawa N, Momotani N, Ito K, Ban Y. Toxic multinodular goitre in a patient with generalized resistance to thyroid hormone who harbours the R429Q mutation in the thyroid hormone receptor beta gene. Clin Endocrinol (Oxf) 2001; 54: 121-124.

https://doi.org/10.1046/j.1365-2265.2001.01033.x

Weiss RE, Hayashi Y, Nagaya T, Petty KJ, Murata Y, Tunca H, et al. Dominant inheritance of resistance to thyroid hormone not linked to defects in the thyroid hormone receptor alpha or beta genes may be due to a defective cofactor. J Clin Endocrinol Metab 1996; 81: 4196-4203.

https://doi.org/10.1210/jcem.81.12.8954015

Fukata S, Brent GA, Sugawara M. Resistance to thyroid hormone in Hashimoto's thyroiditis. N Engl J Med 2005; 352: 517-518.

https://doi.org/10.1056/NEJM200502033520523

Sato H, Sakai H. A family showing resistance to thyroid hormone associated with chronic thyroiditis and its clinical features: A case report. Endocr J 2006; 53: 421-425.

https://doi.org/10.1507/endocrj.K05-182

Ogawa K, Yoshida M, Hayashi Y, Murata Y, Miyata M, Oiso Y. A rare case of resistance to thyroid hormone coexisting with Graves' disease. Endocrine 2011; 40: 318-319.

https://doi.org/10.1007/s12020-011-9491-0

Sato H. Clinical features of primary hyperthyroidism caused by Graves' disease admixed with resistance to thyroid hormone (P453T). Endocr J 2010; 57: 687-692.

https://doi.org/10.1507/endocrj.K10E-066

Sivakumar T, Chaidarun S. Resistance to thyroid hormone in a patient with coexisting Graves' disease. Thyroid 2010; 20: 213-216.

https://doi.org/10.1089/thy.2009.0175

Anzai R, Adachi M, Sho N, Muroya K, Asakura Y, Onigata K. Long-term 3,5,3'-triiodothyroacetic acid therapy in a child with hyperthyroidism caused by thyroid hormone resistance: pharmacological study and therapeutic recommendations. Thyroid 2012; 22: 1069-1075.

https://doi.org/10.1089/thy.2011.0450

Safer JD, Cohen RN, Hollenberg AN, Wondisford FE. Defective release of corepressor by hinge mutants of the thyroid hormone receptor found in patients with resistance to thyroid hormone. J Biol Chem 1998; 273: 30175-30182.

https://doi.org/10.1074/jbc.273.46.30175

Wagner RL, Apriletti JW, McGrath ME, West BL, Baxter JD, Fletterick RJ. A structural role for hormone in the thyroid hormone receptor. Nature 1995; 378: 690-697.

https://doi.org/10.1038/378690a0

Collingwood TN, Adams M, Tone Y, Chatterjee VK. Spectrum of transcriptional, dimerization, and dominant negative properties of twenty different mutant thyroid hormone beta-receptors in thyroid hormone resistance syndrome. Mol Endocrinol 1994; 8: 1262-1277.

https://doi.org/10.1210/me.8.9.1262

Feng W, Ribeiro RC, Wagner RL, Nguyen H, Apriletti JW, Fletterick RJ, et al. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science 1998; 280: 1747-1749.

https://doi.org/10.1126/science.280.5370.1747

Bayraktaroglu T, Noel J, Alagol F, Colak N, Mukaddes NM, Refetoff S. Thyroid hormone receptor beta gene mutation (P453A) in a family producing resistance to thyroid hormone. Exp Clin Endocrinol Diabetes 2009; 117: 34-37.

https://doi.org/10.1055/s-2008-1076712

Sarkissian G, Dace A, Mesmacque A, Bony-Trifunovic H, Malezet-Desmoulins C, Torresani J, et al. A novel resistance to thyroid hormone associated with a new mutation (T329N) in the thyroid hormone receptor beta gene. Thyroid 1999; 9: 165-171.

https://doi.org/10.1089/thy.1999.9.165

Sato H, Koike Y, Honma M, Yagame M, Ito K. Evaluation of thyroid hormone action in a case of generalized resistance to thyroid hormone with chronic thyroiditis: discovery of a novel heterozygous missense mutation (G347A). Endocr J 2007; 54: 727-732.

https://doi.org/10.1507/endocrj.K07-014

Furlanetto TW, Kopp P, Peccin S, Gu WX, Jameson JL. A novel mutation (M310L) in the thyroid hormone receptor beta causing resistance to thyroid hormone in a Brazilian kindred and a neonate. Mol Genet Metab 2000; 71: 520-526.

https://doi.org/10.1006/mgme.2000.3088

Magalhaes PK, Rodrigues Dare GL, Rodrigues Dos Santos S, Nogueira CR, de Castro M, Zanini Maciel LM. Clinical features and genetic analysis of four Brazilian kindreds with resistance to thyroid hormone. Clin Endocrinol (Oxf) 2007; 67: 748-753.

https://doi.org/10.1111/j.1365-2265.2007.02956.x

Matsushita A, Misawa H, Andoh S, Natsume H, Nishiyama K, Sasaki S, et al. Very strong correlation between dominant negative activities of mutant thyroid hormone receptors and their binding avidity for corepressor SMRT. J Endocrinol 2000; 167: 493-503.

https://doi.org/10.1677/joe.0.1670493

Weiss RE, Xu J, Ning G, Pohlenz J, O'Malley BW, Refetoff S. Mice deficient in the steroid receptor co-activator 1 (SRC-1) are resistant to thyroid hormone. EMBO J 1999; 18: 1900-1904.

https://doi.org/10.1093/emboj/18.7.1900

Kim HK, Kim D, Yoo EH, Lee JI, Jang HW, Tan AH, et al. A case of resistance to thyroid hormone with thyroid cancer. J Korean Med Sci 2010; 25: 1368-1371.

https://doi.org/10.3346/jkms.2010.25.9.1368

Paragliola RM, Lovicu RM, Locantore P, Senes P, Concolino P, Capoluongo E, et al. Differentiated thyroid cancer in two patients with resistance to thyroid hormone. Thyroid 2011; 21: 793-797.

https://doi.org/10.1089/thy.2010.0233

Alberto G, Novi RF, Scalabrino E, Trombetta A, Seardo MA, Maurino M, et al. Atrial fibrillation and mitral prolapse in a subject affected by Refetoff syndrome. Minerva Cardioangiol 2002; 50: 157-160.

Kahaly GJ, Matthews CH, Mohr-Kahaly S, Richards CA, Chatterjee VK. Cardiac involvement in thyroid hormone resistance. J Clin Endocrinol Metab 2002; 87: 204-212.

https://doi.org/10.1210/jcem.87.1.8170

Pulcrano M, Palmieri EA, Mannavola D, Ciulla M, Campi I, Covelli D, et al. Impact of resistance to thyroid hormone on the cardiovascular system in adults. J Clin Endocrinol Metab 2009; 94: 2812-2816.

https://doi.org/10.1210/jc.2009-0096

Dhingra S, Owen PJ, Lazarus JH, Amin P. Resistance to thyroid hormone in pregnancy. Obstet Gynecol 2008; 112: 501-503.

https://doi.org/10.1097/AOG.0b013e3181809e3a

Kane S, Fox R, Close C. Thyroid hormone resistance and pregnancy. BJOG 2003; 110: 633-634.

https://doi.org/10.1046/j.1471-0528.2003.01192.x

Kourides IA, Ridgway EC, Weintraub BD, Bigos ST, Gershengorn MC, Maloof F. Thyrotropin-induced hyperthyroidism: use of alpha and beta subunit levels to identify patients with pituitary tumors. J Clin Endocrinol Metab 1977; 45: 534-543.

https://doi.org/10.1210/jcem-45-3-534

Beck-Peccoz P, Persani L. Medical management of thyrotropin-secreting pituitary adenomas. Pituitary 2002; 5: 83-88.

https://doi.org/10.1023/A:1022360414062

Beck-Peccoz P, Persani L. Thyrotropinomas. Endocrinol Metab Clin North Am 2008; 37: 123-134, viii-ix.

https://doi.org/10.1016/j.ecl.2007.10.001

Kienitz T, Quinkler M, Strasburger CJ, Ventz M. Long-term management in five cases of TSH-secreting pituitary adenomas: a single center study and review of the literature. Eur J Endocrinol 2007; 157: 39-46.

https://doi.org/10.1530/EJE-07-0098

Safer JD, Colan SD, Fraser LM, Wondisford FE. A pituitary tumor in a patient with thyroid hormone resistance: a diagnostic dilemma. Thyroid 2001; 11: 281-291.

https://doi.org/10.1089/105072501750159750

Salmela PI, Wide L, Juustila H, Ruokonen A. Effects of thyroid hormones (T4,T3), bromocriptine and Triac on inappropriate TSH hypersecretion. Clin Endocrinol (Oxf) 1988; 28: 497-507.

https://doi.org/10.1111/j.1365-2265.1988.tb03684.x

Dundar B, Bober E, Buyukgebiz A. Successful therapy with L-T4 in a 5 year-old boy with generalized thyroid hormone resistance. J Pediatr Endocrinol Metab 2003; 16: 1051-1056.

https://doi.org/10.1515/JPEM.2003.16.7.1051

Iglesias P, José-Díez J. Posibilidades terapéuticas en la resistencia hipofisaria selectiva a las hormonas tiroideas. Med Clin (Barc) 2008; 130: 345-350.

https://doi.org/10.1157/13117351

Weiss RE, Refetoff S. Treatment of resistance to thyroid hormone--primum non nocere. J Clin Endocrinol Metab 1999; 84: 401-404.

https://doi.org/10.1210/jcem.84.2.5534

Beck-Peccoz P, Medri G, Piscitelli G, Mariotti S, Bertoli A, Barbarino A, et al. Treatment of inappropriate secretion of thyrotropin with somatostatin analog SMS 201-995. Horm Res 1988; 29: 121-123.

https://doi.org/10.1159/000180986

Kannan S, Safer JD. Finding the right balance between resistance and sensitivity: a review of the cardiac manifestations of the syndrome of resistance to thyroid hormone and the implications for treatment. Endocr Pract 2012; 18: 252-255.

https://doi.org/10.4158/EP11075.RA

Dorey F, Strauch G, Gayno JP. Thyrotoxicosis due to pituitary resistance to thyroid hormones. Successful control with D thyroxine: a study in three patients. Clin Endocrinol (Oxf) 1990; 32: 221-228.

https://doi.org/10.1111/j.1365-2265.1990.tb00858.x

Hamon P, Bovier-Lapierre M, Robert M, Peynaud D, Pugeat M, Orgiazzi J. Hyperthyroidism due to selective pituitary resistance to thyroid hormones in a 15-month-old boy: efficacy of D-thyroxine therapy. J Clin Endocrinol Metab 1988; 67: 1089-1093.

https://doi.org/10.1210/jcem-67-5-1089

Takeda T, Suzuki S, Liu RT, DeGroot LJ. Triiodothyroacetic acid has unique potential for therapy of resistance to thyroid hormone. J Clin Endocrinol Metab 1995; 80: 2033-2040.

https://doi.org/10.1210/jc.80.7.2033

Ueda S, Takamatsu J, Fukata S, Tanaka K, Shimizu N, Sakata S, et al. Differences in response of thyrotropin to 3,5,3'-triiodothyronine and 3,5,3'-triiodothyroacetic acid in patients with resistance to thyroid hormone. Thyroid 1996; 6: 563-570.

https://doi.org/10.1089/thy.1996.6.563

Darendeliler F, Bas F. Successful therapy with 3,5,3'-triiodothyroacetic acid (TRIAC) in pituitary resistance to thyroid hormone. J Pediatr Endocrinol Metab 1997; 10: 535-538.

https://doi.org/10.1515/JPEM.1997.10.5.535

Radetti G, Persani L, Molinaro G, Mannavola D, Cortelazzi D, Chatterjee VK, et al. Clinical and hormonal outcome after two years of triiodothyroacetic acid treatment in a child with thyroid hormone resistance. Thyroid 1997; 7: 775-778.

https://doi.org/10.1089/thy.1997.7.775

de Luis DA, Lahera M, Botella JI, Valero MA, Varela C. Eficacia de la quinagolida en el tratamiento de un paciente con resistencia hipofisiaria a hormonas tiroideas. An Med Interna (Madrid) 2001; 18: 259-261.

https://doi.org/10.4321/S0212-71992001000500007

Dulgeroff AJ, Geffner ME, Koyal SN, Wong M, Hershman JM. Bromocriptine and Triac therapy for hyperthyroidism due to pituitary resistance to thyroid hormone. J Clin Endocrinol Metab 1992; 75: 1071-1075.

https://doi.org/10.1210/jcem.75.4.1400873

Cómo citar
1.
Gutiérrez Restrepo J, Montoya Escobar JF. Síndrome de resistencia a las hormonas tiroideas: reporte de un caso. Med. Lab. [Internet]. 1 de marzo de 2013 [citado 28 de marzo de 2020];19(3-4):161-7. Disponible en: https://medicinaylaboratorio.com/index.php/myl/article/view/221
Publicado
2013-03-01
Sección
Casos clínicos